EGFR-IN-35

EGFR-IN-35 is a potent and low-toxicity acrylamide-based EGFR inhibitor. It is a valuable research tool for studying EGFR-driven pathologies, such as non-small cell lung cancer (NSCLC), in both cellular and animal models of disease.